The contribution of medicine to society has been proven; They have improved our quality of life and treatment satisfaction, and have prolonged our lives. To date, our perceptions of the sustainable supply of life-saving medicines have remained unchanged.
However, in the last five years, drug shortages have become a serious threat – especially for children, the elderly, and people with rare diseases. You can browse the web for the FDA's list of drug shortages.
In the scheme of things, drug shortages are increasing. Currently, about 11% of all FDA-approved drugs, vaccines, and other organic products have defects. Injection products; There may be a vaccine shortage followed by some oral medications.
Recognizing a drug deficiency is not easy. The Federal Food and Drug Administration (FDA) views drug shortages as a situation in which the combined contribution of all the clinically interchangeable versions of the FDA-regulated drug is insufficient to meet current or projected consumer demand.
Although drug shortages occur for many reasons, consequences for both the provider and the patient are unavoidable. Some patients may turn to more expensive or less effective drugs, while others may limit access to drugs.
Additional labor costs arise in case of congestion as healthcare providers use their resources to track inventory, send messages, and reconnect with patients after treatment is complete.
Pharmaceutical companies also compete with companies that can obtain rights to sell drugs. With marketing rights, these companies have significant influence over drug access and manufacturing.